This probably reflects the multifactorial nature of open-globe injuries and the numerous mechanisms that are thought to be involved in the development of ocular hypertension and secondary glaucoma ...

NEW YORK, Feb. 05, 2025 (GLOBE NEWSWIRE ... for the treatment of Resistant Hypertension (BOLD-HTN). MANP was originally discovered by John C. Burnett Jr., MD, Director of the Cardiorenal ...

Jan. 30, 2025 (GLOBE NEWSWIRE ... function and pulmonary hemodynamics in patients with Group 2 Pulmonary Hypertension in Heart Failure with Preserved Ejection Fraction (“PH-HFpEF”).

Purpose: Evaluate predictors and outcomes of ocular hypertension after open-globe injury. Patients and Methods: This is a retrospective, case-control study reviewing records of consecutive ...

MANP was originally discovered by John C. Burnett Jr., MD, Director of the Cardiorenal Research Laboratory at Mayo Clinic. E-Star and Mayo Clinic entered into a worldwide exclusive license agreement ...

Detailed price information for Tectonic Therapeutic Inc (TECX-Q) from The Globe and Mail including charting and trades.